Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers ...

The faster patients can be diagnosed with multiple sclerosis the sooner they can begin taking the powerful medications that can prevent further brain damage. This fall, Lancet Neurology published new ...

The ACP received funding to help interpret research and support decisions about MS treatments for older adults with MS.

Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a four-dimensional brain map that reveals how lesions similar to those seen in ...

NIH study reveals key players underlying disease onset and repair. Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a ...

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a new study aims to challenge that approach, presenting evidence that MS may ...